12.11.2018

Disclosure of Regulated Information as per Law 3556/2007

Diagnostic & Therapeutic Center of Athens HYGEIA SA (Issuer), acting in compliance with the legislation in force, announces the following:

A. based on information received on November 9, 2018, from CVC Capital Partners SICAV-FIS SA (CVC SICAV) – acting on its behalf and on behalf of the companies controlled by it, i.e. CVC Capital Partners 2013 PCC, CVC MMXII Limited, CVC Portfolio Holdings Limited, CVC Group Holdings LP, CVC Capital Partners Finance Limited, CVC Capital Partners VI Limited, Hippocrates Holdings Jersey Limited, Hellenic Healthcare S.à.r.l and Hellenic Healthcare Single-Member Holdings SA (Hellenic Healthcare SA or CVC Entities when acting jointly with the aforementioned companies) – on November 9, 2018, Hellenic Healthcare SA  acquired 215,189,466 ordinary registered shares of the Issuer in total, which correspond to approximately 70.38% of the total share capital and voting rights of the Issuer.

B. based on information received on November 12, 2018, from Marfin Investment Group Holdings SA (MIG), on November 9, 2018, MIG sold 215,189,466 ordinary registered shares of the Issuer in total, which correspond to approximately 70.38% of the total share capital and voting rights of the Issuer. Specifically, MIG sold 100,165,506 shares and voting rights of the Issuer held directly and 115,023,960 shares and voting rights held indirectly through its subsidiary Marfin Capital SA.

As a result, the voting right percentage of the Issuer held directly by Hellenic Healthcare SA and indirectly by each one of the other CVC Entities comes to 70.38%.  Respectively, the direct and indirect holding percentage of MIG in the Issuer comes to 0%.

This announcement constitutes regulated information, disclosed in compliance with the provisions of Law 3556/2007 and decision no. 1/434/3.7.2007 issued by the Board of Directors of the Hellenic Capital Market Commission, and has been posted in the Issuer's website (www.hygeia.gr).